Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,590,147
+$495,047 QoQ
Shares Held
14,267
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,530
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Greenwich Wealth Management LLC holds $17,338,236 across 10 Drug Manufacturers - General names. ABBV ranks #1 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
14,267 | $3,590,147 | |
| 2 | PFE |
Pfizer Inc
|
140,297 | $3,378,351 | |
| 3 | LLY |
ELI LILLY & Co
|
2,759 | $3,309,227 | |
| 4 | NVS |
Novartis AG
|
11,294 | $1,769,995 | |
| 5 | GSK |
GSK plc
|
31,884 | $1,671,359 | |
| 6 | JNJ |
Johnson & Johnson
|
4,468 | $1,134,737 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,081 | $909,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,467 | $817,040 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,590,147 | 14,267 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,095,100 | 14,231 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,247,756 | 14,214 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,252,210 | 14,046 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,606,847 | 14,044 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,941,660 | 14,040 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,531,514 | 14,246 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,808,560 | 14,222 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,433,525 | 14,188 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,584,727 | 14,194 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,181,667 | 14,078 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,110,689 | 14,160 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,773,855 | 13,166 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,128,386 | 13,355 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,151,513 | 13,313 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,733,456 | 12,916 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,085,886 | 13,619 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,093,812 | 12,916 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,752,617 | 12,944 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,394,219 | 12,925 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,342,105 | 11,915 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,383,592 | 12,785 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,331,124 | 12,423 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,041,620 | 11,892 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,167,065 | 11,887 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $888,756 | 11,665 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||